GNP CALAMINE TOPICAL SUSPENSION- calamine 8% and zinc oxide 8% lotion 
Amerisource Bergen

----------

GNP Calamine Topical Suspension

Drug Facts

active Ingredients

Calamine 8%

Zinc Oxide 8%

Purpose

Skin Protectant

Skin Protectant

Uses

Dries the oozing and weeping of poison ivy, poison oak, and poison sumac and other skin irritations.

Warnings

For external use only. Use only as directed.

Avoid contat with eyes and moucous membranes.

Ask a doctor

before using on children under 6 years of age.

Stop use and ask a doctor if

Keep out of reach of children.

In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.

Directions

Adults and children 6 mo. of age and older: Shake well before using. Cleanse the skin with soap and water. Let dry before each use. Apply lotion to the affected area using cotton or soft cloth, as often as needed for comfort.

Children under 6 mo. of age: Consult a doctor before use.

Other information

Store at room temperature 15-30C (59-86F)

Inactive Ingredients

Bentonite Magma, Calcium Hydroxide, Glycerin, and Purified Water.

Distributed by: AmrisourceBergen

1300 Morris Drive, Chesterbrooke, PA 19807

Questions or Comments?

Principal Display Panel

GNPCal.jpglabel

GNP CALAMINE TOPICAL SUSPENSION 
calamine 8% and zinc oxide 8% lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:24385-413
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION160 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BENTONITE (UNII: A3N5ZCN45C)  
CALCIUM HYDRIDE (UNII: WY779SQ0XW)  
GLYCERIN (UNII: PDC6A3C0OX)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:24385-413-96177 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product11/16/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01601/01/2008
Labeler - Amerisource Bergen (007914906)
Registrant - Pharma Nobis, LLC (118564114)
Establishment
NameAddressID/FEIBusiness Operations
Pharma Nobis, LLC118564114manufacture(24385-413) , pack(24385-413) , label(24385-413) , analysis(24385-413)

Revised: 12/2023
Document Id: 0c827e0d-14a2-ad56-e063-6394a90a0de5
Set id: 777b0e66-1bce-4483-9dad-c46796fd6f23
Version: 5
Effective Time: 20231214
 
Amerisource Bergen